| Bioactivity | Dutacatib is inhibitor for SARS-CoV-2 3CLpro and cathepsin K, which exhibits antiviral activity and ameliorates the cancer-induced bone diseases[1][2]. |
| CAS | 501000-36-8 |
| Formula | C23H31N7O |
| Molar Mass | 421.54 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Sousa S, et al., Bone-Targeted Therapies in Cancer-Induced Bone Disease. Calcif Tissue Int. 2018 Feb;102(2):227-250. [2]. Dayan Elshan NGR, et al., Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead. J Med Chem. 2024 Feb 22;67(4):2369-2378. |